Oryzon plans to maintain its share capital at €3.03 million and seek admission for new shares on Madrid, Barcelona, Bilbao, and Valencia Stock Exchanges. The biopharmaceutical...
Both projects started on April 1st, 2023, and are expected to last approximately two years. The biopharmaceutical company reduced its losses by 56% in the first...